Cargando…

Di-(2-ethylhexyl) phthalate and autism spectrum disorders

ASDs (autism spectrum disorders) are a complex group of neurodevelopment disorders, still poorly understood, steadily rising in frequency and treatment refractory. Extensive research has been so far unable to explain the aetiology of this condition, whereas a growing body of evidence suggests the in...

Descripción completa

Detalles Bibliográficos
Autores principales: Testa, Chiara, Nuti, Francesca, Hayek, Joussef, De Felice, Claudio, Chelli, Mario, Rovero, Paolo, Latini, Giuseppe, Papini, Anna Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Neurochemistry 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3363982/
https://www.ncbi.nlm.nih.gov/pubmed/22537663
http://dx.doi.org/10.1042/AN20120015
_version_ 1782234471076986880
author Testa, Chiara
Nuti, Francesca
Hayek, Joussef
De Felice, Claudio
Chelli, Mario
Rovero, Paolo
Latini, Giuseppe
Papini, Anna Maria
author_facet Testa, Chiara
Nuti, Francesca
Hayek, Joussef
De Felice, Claudio
Chelli, Mario
Rovero, Paolo
Latini, Giuseppe
Papini, Anna Maria
author_sort Testa, Chiara
collection PubMed
description ASDs (autism spectrum disorders) are a complex group of neurodevelopment disorders, still poorly understood, steadily rising in frequency and treatment refractory. Extensive research has been so far unable to explain the aetiology of this condition, whereas a growing body of evidence suggests the involvement of environmental factors. Phthalates, given their extensive use and their persistence, are ubiquitous environmental contaminants. They are EDs (endocrine disruptors) suspected to interfere with neurodevelopment. Therefore they represent interesting candidate risk factors for ASD pathogenesis. The aim of this study was to evaluate the levels of the primary and secondary metabolites of DEHP [di-(2-ethylhexyl) phthalate] in children with ASD. A total of 48 children with ASD (male: 36, female: 12; mean age: 11±5 years) and age- and sex-comparable 45 HCs (healthy controls; male: 25, female: 20; mean age: 12±5 years) were enrolled. A diagnostic methodology, based on the determination of urinary concentrations of DEHP metabolites by HPLC-ESI-MS (HPLC electrospray ionization MS), was applied to urine spot samples. MEHP [mono-(2-ethylhexenyl) 1,2-benzenedicarboxylate], 6-OH-MEHP [mono-(2-ethyl-6-hydroxyhexyl) 1,2-benzenedicarboxylate], 5-OH-MEHP [mono-(2-ethyl-5-hydroxyhexyl) 1,2-benzenedicarboxylate] and 5-oxo-MEHP [mono-(2-ethyl-5-oxohexyl) 1,2-benzenedicarboxylate] were measured and compared with unequivocally characterized, pure synthetic compounds (>98%) taken as standard. In ASD patients, significant increase in 5-OH-MEHP (52.1%, median 0.18) and 5-oxo-MEHP (46.0%, median 0.096) urinary concentrations were detected, with a significant positive correlation between 5-OH-MEHP and 5-oxo-MEHP (r(s) = 0.668, P<0.0001). The fully oxidized form 5-oxo-MEHP showed 91.1% specificity in identifying patients with ASDs. Our findings demonstrate for the first time an association between phthalates exposure and ASDs, thus suggesting a previously unrecognized role for these ubiquitous environmental contaminants in the pathogenesis of autism.
format Online
Article
Text
id pubmed-3363982
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher American Society for Neurochemistry
record_format MEDLINE/PubMed
spelling pubmed-33639822012-06-12 Di-(2-ethylhexyl) phthalate and autism spectrum disorders Testa, Chiara Nuti, Francesca Hayek, Joussef De Felice, Claudio Chelli, Mario Rovero, Paolo Latini, Giuseppe Papini, Anna Maria ASN Neuro Research Article ASDs (autism spectrum disorders) are a complex group of neurodevelopment disorders, still poorly understood, steadily rising in frequency and treatment refractory. Extensive research has been so far unable to explain the aetiology of this condition, whereas a growing body of evidence suggests the involvement of environmental factors. Phthalates, given their extensive use and their persistence, are ubiquitous environmental contaminants. They are EDs (endocrine disruptors) suspected to interfere with neurodevelopment. Therefore they represent interesting candidate risk factors for ASD pathogenesis. The aim of this study was to evaluate the levels of the primary and secondary metabolites of DEHP [di-(2-ethylhexyl) phthalate] in children with ASD. A total of 48 children with ASD (male: 36, female: 12; mean age: 11±5 years) and age- and sex-comparable 45 HCs (healthy controls; male: 25, female: 20; mean age: 12±5 years) were enrolled. A diagnostic methodology, based on the determination of urinary concentrations of DEHP metabolites by HPLC-ESI-MS (HPLC electrospray ionization MS), was applied to urine spot samples. MEHP [mono-(2-ethylhexenyl) 1,2-benzenedicarboxylate], 6-OH-MEHP [mono-(2-ethyl-6-hydroxyhexyl) 1,2-benzenedicarboxylate], 5-OH-MEHP [mono-(2-ethyl-5-hydroxyhexyl) 1,2-benzenedicarboxylate] and 5-oxo-MEHP [mono-(2-ethyl-5-oxohexyl) 1,2-benzenedicarboxylate] were measured and compared with unequivocally characterized, pure synthetic compounds (>98%) taken as standard. In ASD patients, significant increase in 5-OH-MEHP (52.1%, median 0.18) and 5-oxo-MEHP (46.0%, median 0.096) urinary concentrations were detected, with a significant positive correlation between 5-OH-MEHP and 5-oxo-MEHP (r(s) = 0.668, P<0.0001). The fully oxidized form 5-oxo-MEHP showed 91.1% specificity in identifying patients with ASDs. Our findings demonstrate for the first time an association between phthalates exposure and ASDs, thus suggesting a previously unrecognized role for these ubiquitous environmental contaminants in the pathogenesis of autism. American Society for Neurochemistry 2012-05-30 /pmc/articles/PMC3363982/ /pubmed/22537663 http://dx.doi.org/10.1042/AN20120015 Text en © 2012 The Author(s). http://creativecommons.org/licenses/by-nc/2.5/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Testa, Chiara
Nuti, Francesca
Hayek, Joussef
De Felice, Claudio
Chelli, Mario
Rovero, Paolo
Latini, Giuseppe
Papini, Anna Maria
Di-(2-ethylhexyl) phthalate and autism spectrum disorders
title Di-(2-ethylhexyl) phthalate and autism spectrum disorders
title_full Di-(2-ethylhexyl) phthalate and autism spectrum disorders
title_fullStr Di-(2-ethylhexyl) phthalate and autism spectrum disorders
title_full_unstemmed Di-(2-ethylhexyl) phthalate and autism spectrum disorders
title_short Di-(2-ethylhexyl) phthalate and autism spectrum disorders
title_sort di-(2-ethylhexyl) phthalate and autism spectrum disorders
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3363982/
https://www.ncbi.nlm.nih.gov/pubmed/22537663
http://dx.doi.org/10.1042/AN20120015
work_keys_str_mv AT testachiara di2ethylhexylphthalateandautismspectrumdisorders
AT nutifrancesca di2ethylhexylphthalateandautismspectrumdisorders
AT hayekjoussef di2ethylhexylphthalateandautismspectrumdisorders
AT defeliceclaudio di2ethylhexylphthalateandautismspectrumdisorders
AT chellimario di2ethylhexylphthalateandautismspectrumdisorders
AT roveropaolo di2ethylhexylphthalateandautismspectrumdisorders
AT latinigiuseppe di2ethylhexylphthalateandautismspectrumdisorders
AT papiniannamaria di2ethylhexylphthalateandautismspectrumdisorders